GMED

66.8902.49%
AD

Ann D. Rhoads

Independent Director

Ms. Ann D. Rhoads served as an Independent Director for Evoke Pharma, Inc. since 2021 until 2022. She has been an Independent Director of Repare Therapeutics Inc. since June 10, 2020. Ms. Rhoads has been Independent Director of QuidelOrtho Corporation (formerly known as Quidel Corporation) since August 24, 2020 and ALASTIN Skincare, Inc. since March 2018. She served as the Chief Financial Officer of Forty Seven, Inc. since March 2018 until June 2020. Ms. Rhoads was a Director of Iteos Therapeutics S.A. and Independent Director of iTeos Therapeutics, Inc. since June 2020 until August 29, 2025. From January 2017 to March 2017, she was a consultant to Zogenix, Inc. She served as the Chief Financial Officer, Executive Vice President, Secretary and Treasurer at Zogenix, Inc. since March 2010 until January 16, 2017. Ms. Rhoads served as the Chief Financial Officer at Premier Healthcare Alliance, LP since 2000 until December 2009 and served as its Senior Vice President. From 1993 to 1998, she served as an investment professional at Sprout Group and she served as Vice President of Sprout Capital IX, L.P. and Sprout Capital X, L.P. She served as Vice President, Strategic Initiatives at Premier, Inc. from August 1998 to 2000. Prior to joining Sprout, Ms. Rhoads served as a Management Consultant of Bain & Company Inc., where she concentrated on strategy and competitive analysis. She worked at Fresenius Kabi Pharmaceuticals Holding, Inc. She spent years with Merrill Lynch in its private equity/LBO group, Merrill Lynch Capital Partners Inc. (now Stonington Partners) and in its Mergers & President, Strategic Initiatives at Premier Inc. She served as Senior Vice President of Premier, Inc. and was its Chief Financial Officer from 2000 to 2009. From 1993 to 1998, Ms. Rhoads served as Vice President of Sprout Group, a venture capital affiliate of Donaldson, Lufkin & Jenrette (now part of Credit Suisse First Boston). She was a Director of IRIDEX Corporation since July 18, 2017 until October 15, 2018. Ms. Rhoads is a member of the boards of Directors of Counsyl, Inc. She had been an Independent Director of Novellus Systems Inc. since February 2003 and has been Independent Director at Globus Medical, Inc. since July 29, 2011. She served as an Independent Director of Evoke Pharma, Inc, since June 2013 until May 13, 2021. Ms. Rhoads received a B.S. in Business Administration in Finance from the University of Arkansas and an MBA from Harvard Business School.

Positions